Jürgen Schnaubelt graduated in chemistry from the Technical University of Darmstadt and received his PhD in organic chemistry from the Technical University of Dresden. After a postdoctoral stay at the University of Cambridge, he joined Boehringer Ingelheim.
At Boehringer Ingelheim, he held various positions, including process development and R&D project management. In 2021, he was appointed Director Early Drug Substance Development.
Juergen has more than 25 years of professional experience, including HPAPI handling and manufacturing.